HHS prepares for an enrollment surge on March 31
On March 25, the federal healthcare.gov site experienced the second consecutive day of more than 1 million visitors. With all this last-minute traffic, instinct tells me technical problems are a real possibility in the waning days of open enrollment.
Federal officials, however, promise that healthcare.gov is prepared for the expected surge and can manage 100,000 concurrent users, meanwhile, the call center is staffed with 14,000 reps.
“We know people will wait until the last minute,” says Julie Bataille, director of communications for the Department of Health and Human Services (HHS).
HHS does not have the statutory authority to extend open enrollment past March 31, but consumers aren’t completely out of luck. For example, private health insurers have the leeway to offer forgiveness to procrastinators.
“There may be situations, depending on what plans offer, where consumers will be able to get coverage outside of the Marketplace, but that is at the issuer’s choice,” Bataille says. “Marketplace open enrollment ends March 31, which means most consumers will not have another opportunity to enroll until next year.”
For those who get stuck waiting in line when the clock strikes midnight on Monday, HHS is willing to allow them to finish the process and get their coverage if they can attest to the fact that they were trying to sign up. Officials are not clear on exactly how or if HHS will verify attestations-which consumers will self-report on their applications.
While Bataille won’t go so far as to say it’s the honor system, she says most people are “truthful” on federal documents. Sounds like the honor system to me.
It could be “a few days to a week or so” for everyone who’s piled up to get through the queue after deadline, Bataille says. That sounds a bit understated to me, too.
The one data point that won’t be understated will be the total number of people signing up for health coverage.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Opzelura May Reduce Need for Other Treatments in Atopic Dermatitis | AAD 2025
March 11th 2025Patients with atopic dermatitis who had not received biologics prior to treatment with Opzelura were able to avoid biologics during the 12 months after treatment with the topical nonsteroidal, finds study at American Academy of Dermatology Association annual meeting.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Supporting Patients with Type 1 Diabetes Through Education, Technology and Transparency
March 10th 2025Arti Masturzo, M.D., chief medical officer of CCS, spoke with MHE in this third part of a video series to share how CCS helps patients with type 1 diabetes effectively use glucose monitors and insulin pumps by providing clear guidance and troubleshooting support, recognizing that even minor errors in management can have significant health consequences.
Read More
Melanoma Treatment Advances Now Crossing into Other Skin Cancers
March 10th 2025Deborah S. Sarnoff, M.D., talks about the recent breakthrough treatments that are paving the way to treat patients with advanced basal cell carcinoma, squamous cell carcinoma and Merkel cell carcinoma, which is a rare and aggressive type of skin cancer.
Read More